Zafgen Reports Fourth Quarter and Full Year 2018 Operating and Financial Results and Provides Key Program and Business Updates - Nasdaq

Zafgen Reports Fourth Quarter and Full Year 2018 Operating and Financial Results and Provides Key Program and Business Updates  Nasdaq

Recently announced positive results for second cohort of Phase 2 clinical trial of ZGN-1061. Updates on progress preparing for FDA Type A meeting.



Comments

Popular posts from this blog

Meet Ratty, the Little Rodent Who Taught Me a Big Lesson - PETA